aTYR PHARMA INC Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

aTYR PHARMA INC reported Revenue From Contract With Customer Excluding Assessed Tax of $190.0 thousand for the year ending 2025.

  • aTYR PHARMA INC showed a decrease of -19.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from aTYR PHARMA INC's annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), aTYR PHARMA INC's Revenue From Contract With Customer Excluding Assessed Tax has declined by 55.0%.
  • Historical annual values: Fiscal year 2025: $190.0 thousand | Fiscal year 2024: $235.0 thousand | Fiscal year 2023: $353.0 thousand | Fiscal year 2022: $10.39 million | Fiscal year 2021: $0.00 | Fiscal year 2020: $10.46 million | Fiscal year 2019: $422.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: